Publication Laka-library:
Report on Molybdenum 99 production for nuclear medicine 2010-2020
Author | AIPES |
6-07-4-60-18.pdf | |
Date | November 2008 |
Classification | 6.07.4.60/18 (MISCELLANEOUS - RADIO ISOTOPES - NUCLEAR MEDICINE / MEDICAL APPLICATIONS ) |
Front |
From the publication:
REPORT ON MOLYBDENUM-99 PRODUCTION FOR NUCLEAR MEDICINE – 2010 – 2020 Association of Imaging Producers & Equipment Suppliers (European Industrial Association for Nuclear Medicine and Molecular Healthcare) November 2008 REPORT ON MOLYBDENUM-99 PRODUCTION FOR NUCLEAR MEDICINE – 2010 – 2020 Project Leader: Jean-Pierre Cabocel, Director General AIPES Participants: Alain Alberman, CEA, Centre de Saclay, France Wim Borneman, Covidien, The Netherlands Kevin Charlton, NRG, The Netherlands Philippe Damhaut, MDS Nordion, Belgium Bernard David, IRE, Belgium Ian Downie, MDS Nordion, Canada Heiko Gerstenberg, Technische Universität München, Germany Marc Gheeraert, President AIPES Jan Kysela, Nuclear Research Institute Rež; Czech Republic Piet Louw, NTP Radioisotopes (Pty) Ltd, South Africa Peter Martin, GE Healthcare Bio-Sciences, UK Hazel Mullin, GE Healthcare Bio-Sciences, UK Bernard Ponsard, SCK.CEN, Belgium Vittorio Puppo, Covidien, Italy Jack Rottier, Covidien, The Netherlands Jean-Marc Saccavini, IBA/CisBio, France Guy Turquet de Beauregard, Vice President AIPES and IBA/CisBio France Jean-Michel Vanderoftstadt, IRE, Belgium Cyrille Villeneuve, Lantheus Medical Imaging Europe, U.K. Richard Zimmermann, IBA Molecular, France Author: Pierre Verbeek, Consultant CYCLOPHARMA LABORATOIRES